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Abstract
Background: Thiamine diphosphate (ThDP) is the active form of thiamine, and it serves as a
cofactor for several enzymes, both cytosolic and mitochondrial. Isolated mitochondria have been
shown to take up thiamine yet thiamine diphosphokinase is cytosolic and not present in
mitochondria. Previous reports indicate that ThDP can also be taken up by rat mitochondria, but
the kinetic constants associated with such uptake seemed not to be physiologically relevant.
Results: Here we examine ThDP uptake by mitochondria from several human cell types, including
cells from patients with thiamine-responsive megaloblastic anemia (TRMA) that lack a functional
thiamine transporter of the plasma membrane. Although mitochondria from normal lymphoblasts
took up thiamine in the low micromolar range, surprisingly mitochondria from TRMA lymphoblasts
lacked this uptake component. ThDP was taken up efficiently by mitochondria isolated from either
normal or TRMA lymphoblasts. Uptake was saturable and biphasic with a high affinity component
characterized by a Km of 0.4 to 0.6 µM. Mitochondria from other cell types possessed a similar high
affinity uptake component with variation seen in uptake capacity as revealed by differences in Vmax
values.
Conclusions: The results suggest a shared thiamine transporter for mitochondria and the plasma
membrane. Additionally, a high affinity component of ThDP uptake by mitochondria was identified
with the apparent affinity constant less than the estimates of the cytosolic concentration of free
ThDP. This finding indicates that the high affinity uptake is physiologically significant and may
represent the main mechanism for supplying phosphorylated thiamine for mitochondrial enzymes.
Background
Thiamine is a water-soluble, B-complex vitamin that can-
not be synthesized by mammals, and thus thiamine can
be obtained only from dietary intake. This can lead to se-
vere consequences in humans when thiamine is limiting;
thiamine deficiency may result in beriberi and the
Wernike-Korsakoff syndrome [1,2]. Being positively
charged and present in relatively low plasma concentra-
tions, thiamine movement across cellular membranes re-
quires transporters. Upon being taken up by a cell,
thiamine is rapidly diphosphorylated by thiamine di-
phosphokinase to give thiamine diphosphate (ThDP) [3].
Thus, thiamine represents only a few percent of the total
cellular thiamine/thiamine phosphate derivatives. ThDP
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both in the cytosol (transketolase) and mitochondria (α-
ketoglutarate dehydrogenase complex being the most
studied example). The intracellular concentration of
ThDP has been estimated at 30 µM, with only about 7 per-
cent being free cytosolic and the remainder being enzyme-
bound with much of this within mitochondria [4,5]. Pre-
vious findings indicate a complex, cell-type dependent
regulation of compartmentalization and intracellular
pools of thiamine and its phosphorylated derivatives in
response to fluctuating extracellular thiamine levels [4–6].
Hence, thiamine transport, including that by mitochon-
dria, is of interest.
Thiamine entry into mammalian cells occurs by a satura-
ble, high affinity transporter that is deficient in humans
with thiamine-responsive megaloblastic anemia (TRMA)
[7–12]. Thiamine uptake by mitochondria has been dem-
onstrated [13], yet thiamine diphosphokinase is cytosolic
and mitochondria cannot convert thiamine to ThDP [14–
16]. Barile and coworkers demonstrated saturable uptake
of ThDP by rat liver mitochondria characterized by a Km
of around 20 µM. Although the estimated concentration,
in mice and human cells, of intracellular ThDP is about 30
µM, much of this is found in a low turnover pool repre-
senting enzyme-bound ThDP [4,17]. The estimated con-
centration of free cytosolic ThDP available for
intracellular transport is about 10% of the total concentra-
tion and thus 2 to 3 µM [4,17,18]. Hence the physiologi-
cal significance of the mitochondrial ThDP uptake just
decribed is uncertain. Within mitochondria, ThDP can be
converted to thiamine monophosphate [19]. Thiamine or
ThDP entry into mitochondria from TRMA cells has not
been studied. Interestingly, ThDP-utilizing enzymes in
mitochondria are much less affected (as revealed by loss
of activity) upon progressive depletion of thiamine avail-
able to TRMA cells than are ThDP-utilizing enzymes of the
cytosol [6]. For these reasons, we have examined the up-
take of thiamine and especially ThDP by mitochondria
from several human cell types, including cells from TRMA
patients.
Results
Uptake of thiamine by cells and mitochondria
Although our interests primarily were in mitochondrial
uptake of thiamine and its derivatives, we first examined
cellular uptake of thiamine by the lymphoblast cell lines
and found thiamine uptake properties typical of other
mammalian cells. Figure 1a indicates thiamine uptake by
normal lymphoblasts and lymphoblasts derived from a
TRMA patient. The high affinity transport of thiamine by
normal lymphoblasts is abolished in the presence of a 100
fold excess of unlabeled thiamine. Under such conditions,
some uptake continues from a low affinity (Km in the mM
range) transport mechanism [3] and/or from diffusion
[20] that characterizes thiamine uptake in all mammalian
cells examined to date. Using an expanded range of thia-
mine concentrations from that shown in fig. 1 in multiple
experiments resulted in a Km of 1.0 ± 0.9 µM for the high
affinity transport by normal lymphoblasts. As expected,
lymphoblasts derived from the TRMA patient showed no
high affinity thiamine transport as revealed by thiamine
uptake being the same in the absence and presence of ex-
cess unlabelled thiamine.
Mitochondria isolated from normal lymphoblasts also
were found to take up thiamine (fig. 1b) in a manner sim-
ilar to that of cellular uptake, with both a high and low af-
finity component. Using an expanded range of thiamine
concentrations in multiple experiments resulted in a Km
of 2.1 ± 0.4 µM for high affinity thiamine uptake by nor-
mal lymphoblast mitochondria. Interestingly, mitochon-
dria from TRMA lymphoblasts did not possess a "high
affinity" thiamine transport capacity as did mitochondria
form normal lymphoblasts. No difference in uptake of
thiamine by TRMA mitochondria was found in the pres-
ence and absence of excess unlabelled thiamine (fig. 1b).
This finding suggests that cellular and mitochondrial up-
take of thiamine may be mediated by the same transporter
since TRMA is defined by mutation within the thiamine
transporter located on the plasma membrane [7–12]. Us-
ing antiserum specific for the human thiamine transporter
that is mutated in TRMA individuals, western analysis
consistently resulted in a faint but detectable band within
the isolated mitochondrial suspension (fig. 1c), even after
extensive and multiple washing.
Uptake of ThDP by mitochondria
Although mitochondria from lymphoblasts (above) and
other mammalian cells [13] were found to take up thia-
mine, the physiological significance of the uptake is un-
known given that thiamine diphosphokinase is cytosolic
and mitochondria cannot convert thiamine to ThDP
[14,16,21]. We thus were interested in uptake of ThDP by
mitochondria, a possibility demonstrated previously with
rat liver [14]. Mitochondria from normal human lym-
phoblasts were able to take up ThDP in a saturable, bipha-
sic manner (fig. 2) with a first saturation in the
submicromolar range (described below) and a second at
much higher concentrations of ThDP. Time course exper-
iments indicated ThDP uptake was linear for at least 20
minutes (data not shown), and uptake was linear with the
amount of mitochondrial protein added (inset of fig. 2).
Although the biphasic nature of the uptake is readily seen
in various plots of the data, the existence of the high affin-
ity component perhaps is best illustrated in fig. 3 in which
the uptake at submicromolar concentrations of ThDP is il-
lustrated (open squares). Uptake of ThDP was repeated inPage 2 of 8
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Uptake of radioactive thiamine by normal and TRMA lymphoblasts and mitochondria isolated from the lym-
phoblasts. A. Late log phase lymphoblasts from normal (squares) or TRMA individuals (circles) were incubated for 30 minutes
with various concentrations of radioactive thiamine. Incubations were carried out in the absence (unfilled symbols) or presence
(filled symbols) of a 100 fold excess of non-radioactive thiamine (at each concentration). Cell-associated counts per minute
were determined, and the velocity (V) (pmol thiamine per 2 × 106 cells per min.) is plotted versus the concentration (in micro-
molar) of radioactive thiamine.). Error bars represent SEM for two independent experiments. B. Mitochondria were isolated
from lymphoblasts derived from normal (squares) or TRMA individuals (circles) were incubated for 15 minutes with various
concentrations of radioactive thiamine. Incubations were carried out in the absence (unfilled symbols) or presence (filled sym-
bols) of a 100 fold excess of non-radioactive thiamine (at each concentration). Mitochondrial-associated counts per minute
were determined, and the velocity (V) (pmol thiamine per mg mitochondrial protein per min.) is plotted versus the concentra-
tion (in micromolar) of thiamine.). Error bars represent ± SEM for two independent experiments. C. Western anaylsis indicat-
ing the presence of the thiamine transporter in plasma membrane fractions and in mitochondrial fractions. Equivalent volumes
of subcellular fractions were electrophoretically separated, blotted to a filter, and probed using antisera specific for the human
thiamine transporter that is mutated in TRMA individuals. Lane 1, plasma membrane fraction; 2, initial mitochondrial fraction; 3
and 4, successive washes of the mitochondrial fraction; 5, final mitochondrial fraction. 75 micrograms of protein were loaded
into each lane with the exception of the lanes containing the washes (3 and 4) which were not quantitated. A faint but repro-
ducible (using different preparations) band was found in the final mitochondrial fraction.Page 3 of 8
(page number not for citation purposes)
BMC Biochemistry 2002, 3 http://www.biomedcentral.com/1471-2091/3/8the presence of 30 µM non-radioactive ThDP, a concentra-
tion that is 100 to about 40 fold excess over the concen-
tration of radioactive ThDP that was used. Given the Km
values for the high and low affinity components (see be-
low), this excess should abolish most of the high affinity
uptake but have little to no effect on the low affinity up-
take. The uptake due solely to the low affinity component
was calculated using the kinetic parameters determined
for this component and was plotted as open triangles. As
seen in fig. 3, uptake in the presence of 30 µM non-radio-
active ThDP (open circles) was essentially identical to that
calculated for the low affinity component and abolition of
the high affinity uptake indeed was observed.
Using the data from 4 independent experiments resulted
in the determination of a Km of 0.38 µM for the high af-
finity (table 1) and 115 µM for the low affinity uptake
components. The high affinity Km value compares favora-
bly with the estimated 2 to 3 µM intracellular concentra-
tion of free ThDP.
Figure 2
The rate of uptake of ThDP by mitochondria isolated
from normal lymphoblasts. Mitochondria were isolated
from normal lymphoblasts and were incubated for 15 min-
utes with various concentrations of radioactive ThDP. Mito-
chondrial-associated counts were determined, and the
velocity (V) (pmol ThDP per mg mitochondrial protein per
min.) is plotted versus the concentration in micromolar of
ThDP ([S]). Error bars represent SEM for four independent
experiments. The inset shows uptake (V, pmol ThDP per mg
mitochondrial protein per min.) versus varying amounts of
resuspended mitochondria (µg of protein) in the presence of
2 M radioactive ThDP.
Figure 3
The rate of uptake of ThDP at submicromolar con-
centrations by mitochondria from normal lymphob-
lasts. Mitochondria were isolated from normal lymphoblasts
and were incubated for 15 minutes with various concentra-
tions of radioactive ThDP in the absence (open squares) or
presence (open circles) of 30 µM nonradioactive ThDP.
Mitochondrial-associated counts were determined, and the
velocity (V) (pmol ThDP per mg mitochondrial protein 15
min.) is plotted versus the concentration in micromolar of
radioactive ThDP ([S]). The calculated V versus [S] for the
low affinity component only, using the kinetic parameters for
that component, also is plotted (open triangles). Error bars
represent ± SEM for four independent experiments in the
absence and three experiments in the presence of non-radio-
active ThDP.
Table 1: Kinetic constants for the high affinity component of 
ThDP uptake by mitochondria isolated from various cell types.
cell line Km Vmax
normal lymphoblasts 0.38 2.0




Km, micromolar; Vmax, pmol per mg protein per min. Values for nor-
mal lymphoblasts are derived from a Lineweaver-Burk plot using the 
mean velocity values averaged from 4 independent experiments. Two 
independent experiments were performed for TRMA lymphoblasts, 
fibroblasts, and neuroblastomas, and one experiment was performed 
for glyB cells.Page 4 of 8
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ThDP in an essentially identical saturable, biphasic fash-
ion as uptake by normal mitochondria (fig. 4). The inset
compares the Lineweaver-Burk plot of the high affinity
uptake component for mitochondria of both cell types. A
high affinity Km of 0.60 (table 1) was calculated for mito-
chondrial uptake of ThDP for TRMA lymphoblasts, a val-
ue that is essentially the same as that for mitochondria
isolated from normal lymphoblasts. The results indicate
that although mitochondria from TRMA lymphoblasts
cannot take up thiamine with high affinity, they can effi-
ciently import ThDP, the active form of thiamine.
Previous work has indicated that different cell types may
differentially regulate intracellular pools of thiamine and/
or its phosphorylated derivatives [6]. Thus, we examined
ThDP uptake by several other cell types. As shown in table
1, high affinity uptake of ThDP by mitochondria from fi-
broblasts and neuroblastoma cells was essentially the
same as that for normal and TRMA lymphoblasts as re-
vealed by the similar Km values. The apparent affinity for
ThDP characteristic of the high affinity uptake component
was essentially identical for all cell types examined, how-
ever variation was seen in transport capacity, as revealed
by substantially different values for Vmax (table 1). Mito-
chondria from all of the cell types examined also pos-
sessed the low affinity uptake characterized by Km's
similar to that of normal lymphoblasts but with a greater
range of values being found (20 to 115 µM).
The final entry in table 1 is for ThDP uptake by mitochon-
dria isolated from glyB cells. GlyB cells are a Chinese ham-
ster ovary cell line that is deficient in the transport of
folate into mitochondria. For reasons discussed below,
ThDP uptake was examined in these cells. As seen in table
1, high affinity uptake was found with kinetic constants
similar to those of the human cell types. The low affinity
uptake component was also similar to that by human mi-
tochondria (data not shown).
Discussion + Conclusion
As has been reported for mitochondria of rat liver [13],
mitochondria from human lymphoblasts were found
herein to take up thiamine in a saturable manner charac-
terized by a Km of 2.1 µM. Upon entry into a cell, thiamine
is rapidly diphosphorylated to ThDP, resulting in a low
intracellular thiamine concentration [4,17]. The Km deter-
mined here is about an order of magnitude greater than
the estimated intracellular thiamine concentration [4],
raising questions about the efficiency of such uptake.
Surprisingly, mitochondria derived from TRMA lymphob-
lasts lacked the high affinity uptake of thiamine. TRMA is
caused by mutations which destroy the high affinity thia-
mine transporter of the plasma membrane [7–12]. The
similar Km values found for cellular and mitochondrial
uptake of thiamine for normal lymphoblasts and the lack
of such uptake by TRMA mitochondria and TRMA cells
suggests that high affinity thiamine import into mito-
chondria may be carried out by the same transporter or a
variant form, perhaps generated by differential splicing, of
that serving on the plasma membrane. Although western
analysis using anti-human transporter (that is mutated in
TRMA individuals) antiserum supports this interpreta-
tion, further experiments need to be carried out to sub-
stantiate the suggestion of a shared thiamine transporter
between these two membrane systems. Even if true, the
physiological significance of thiamine uptake by mito-
chondria is unknown since mitochondria cannot form
ThDP from thiamine [14–16].
We find that mitochondria from a variety of human cell
types efficiently take up ThDP. Uptake is biphasic with a
high and a low affinity component. The Km values charac-
teristics of the high affinity uptake component (all around
0.4 µM) are comparable to the estimated intracellular
Figure 4
The rate of uptake of ThDP by mitochondria isolated
from normal and TRMA lymphoblasts. Mitochondria
were isolated from normal (open squares) or TRMA (open
circles) lymphoblasts and were incubated for 15 minutes with
various concentrations of radioactive ThDP. Mitochondrial-
associated counts were determined, and the velocity (V)
(pmol ThDP per mg mitochondrial protein per min.) is plot-
ted versus the concentration in micromolar of ThDP ([S]).
The inset shows the Lineweaver-Burk plot (1/V vs. 1/S) of
the high affinity component of ThDP uptake for normal
(open squares) and TRMA (open circles) derived mitochon-
dria.Page 5 of 8
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ThDP of around 3 µM [4]. This suggests that the high af-
finity uptake system is the physiologically relevant mech-
anism responsible for ThDP entry into mitochondria.
Earlier work with rat liver mitochondria identified a ThDP
uptake system with an estimated Km of around 20 µM
[14]. This is of the same order of magnitude that we find
for the low affinity component in the human cells exam-
ined herein. The previous work used a less sensitive proce-
dure of examining ThDP uptake and did not examine
uptake below 10 µM. This would explain the lack of iden-
tification in the previous work of the high affinity uptake
component.
There is a high degree of amino acid similarity among
folate transporters and the thiamine transporter of the
plasma membrane [7–10]. Recently, it was found that in
murine cells there can be a substantial efflux of ThDP me-
diated by the reduced folate carrier protein [22]. GlyB cells
are a Chinese hamster ovary cell line derivative that are de-
ficient in the transport of folates into mitochondria, and
the responsible mitochondrial transporter has recently
been identified and its gene cloned [23]. We wondered if
the mitochondrial folate transporter was responsible for
uptake of ThDP into mitochondria, making analogies to
the ability of the plasma membrane folate transporter be-
ing able to transport ThDP. However, this is not the case
as glyB cells that lack the mitochondrial folate transporter
were found to take up ThDP with high affinity kinetics
similar to that of mitochondria of human cells.
Mitochondria from three human cell types – lymphob-
lasts, fibroblasts, and neruoblastoma cells – all possessed
a high affinity ThDP uptake component characterized by
equivalent apparent affinity for ThDP as revealed by es-
sentially identical Km values. Previous studies indicate the
existence of a complex, cell-type dependent regulation of
compartmentalization and intracellular pools of thiamine
and/or its phosphorylated derivatives in response to fluc-
tuating extracellular thiamine levels [4,6,17]. The cell
lines used here were also used in the studies leading to this
conclusion. Clearly, differences in mitochondrial trans-
porter affinities do not contribute to the cell-type depend-
ent regulation of ThDP compartmentalization. However,
we did find significant differences in ThDP uptake capac-
ity with respect to cell type as revealed by variation in the
Vmax values. Neuroblastoma mitochondria possessed the
largest uptake capacity, having a Vmax 4 to 30 fold higher
than that of the other cell types examined. Interestingly, of
the three cell types neuroblastoma cells also are the most
resistant to changes in mitochondrial ThDP-utilizing en-
zyme activity upon progressive depletion of the thiamine
made available to the cells [6]. This suggests that cell-de-
pendent variation in ThDP uptake capacity by mitochon-
dria may contribute to the cell-dependent regulation of
ThDP compartmentalization. As such regulation was
most clearly revealed upon progressively depleting thia-
mine from cells [6], it will be of interest to examine possi-
ble changes in mitochondrial transport capacity in
response to thiamine depletion.
Studies on the sensitivity of ThDP-utilizing enzymes to
progressive depletion of thiamine that is available to the
cell indicate that such enzymes in mitochondria are signif-
icantly less sensitive than cytosolic enzymes in TRMA cells
[6]. This could be interpreted as efficient import of thia-
mine/ThDP into mitochondria in TRMA cells even though
thiamine inefficiently enters these cells due to the lack of
the high affinity thiamine transporter. Although we found
a lack of mitochondrial uptake of thiamine in TRMA cells,
our finding of an intact, high affinity ThDP transport
mechanism for TRMA mitochondria is consistent with
and offers an explanation for such an interpretation.
Materials and Methods
Radiochemicals
[3H]thiamine (1 Ci/mmol, radiochemical purity greater
than 97%) and [3H]thiamine diphosphate (1.4 Ci/mmol,
radiochemical purity greater than 98 %) were purchased
from Moravek Biochemical Inc (Brea, CA).
Cell culture
Normal lymphoblasts, TRMA lymphoblasts and fibrob-
lasts cell lines were obtained and have been characterized
as described [6]. The human neuroblastoma cells were an
SY-SY5Y cell line, a thrice-cloned subline of SK-N-SH [24].
GlyB cells, a Chinese hamster ovary K1 subline, are defi-
cient in the transport of folate into mitochondria [23] and
were a kind gift from L. Chasin (Columbia University). All
cell types were growth at 37°C in the presence of 10 µM
thiamine in RPMI 1640 medium supplemented with 10%
heat-inactive fetal calf serum, 2 mM L-glutamine and 1 g/
L penicillin/streptomycin, except glyB cells which were
grown in MEM medium. Cells were grown and used at late
log phase or at 80–90% confluency.
Cellular thiamine transport
Cells were harvested, washed four times with 40 ml of ice-
cold transport buffer (145 mM NaCl, 1 mM MgCl2, 1 mM
CaCl2, 10 mM glucose, 10 mM HEPES, pH 7.4), titered,
and preincubated for 30 min. at 37°C after resuspending
3 × 107 cells in 1 ml of transport buffer. Various amounts
of [3H]thiamine (to give submicromolar and micromolar
final concentrations) were added and the reactions were
incubated for 30 min. The specific activity of the radioac-
tive thiamine was the same for each concentration used.
The cells were collected by rapid filtration onto glass fiber
filters (type A/E, Gelman Sciences, Ann Arbor, MI) and
washed via filtration with 10 ml of cold transport buffer.
After thorough drying (overnight at 60°C), the amount ofPage 6 of 8
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scintillation counting [25]. For each concentration, the
uptake in the presence of a 100-fold excess of unlabelled
thiamine was performed to assess the contribution to up-
take from a low affinity (Km in the mM range) component
[3] and/or from diffusion [20].
Isolation of mitochondria
Mitochondria were isolated from about 3 × 108 cells ac-
cording to published procedures [26,27]. The final mito-
chondrial pellet was suspended in suspension buffer (140
mM KCl, 0.3 mM EDTA, 5 mM MgCl2, 10 mM HEPES, pH
7.4) to give a protein concentration of 3–4 mg/ml. Protein
concentration was determined using the Bio-Rad DC Pro-
tein Assay Kit (Bio-Rad Laboratories, Hercules, CA). The
isolation and purity of the mitochondrial preparations
were monitored by western analysis using anti-cyto-
chrome C antiserum and by microscopy. Western analysis
also was performed on the subcellular fractions using an-
tiserum raised against a human thiamine transporter-spe-
cific peptide. The antiserum detects a protein of 55 KD
(predicted size of the plasma membrane thiamine trans-
porter) that is not detected in cells from TRMA individuals
that possess a premature stop codon within the transport-
er gene (unpublished results).
Uptake of thiamine and ThDP by mitochondria
Uptake of thiamine and ThDP by mitochondria was deter-
mined by a rapid filtration procedure [26,28]. Incuba-
tions were performed at 37°C by rapidly mixing 30 µl of
mitochondrial suspension (ca. 100 micrograms of pro-
tein) with 220 µl of incubation buffer (140 mM KCl, 0.3
mM EDTA, 5 mM MgCl2, 10 mM Mes, pH 6.5) containing
labeled thiamine or ThDP at various concentrations. The
uptake was stopped at 15 min. by the addition of 2 ml of
ice-cold stop buffer (100 mM KCl, 100 mM mannitol, 10
mM potassium phosphate, pH 7.4) and the mitochondria
were collected by rapid filtration on 0.45 µM Millipore
membrane filters. The filters were immediately washed
with 5 ml of stop buffer via filtration, and they were sub-
sequently dried at 60°C overnight. The amount of labeled
thiamine or ThDP taken up by the mitochondria was de-
termined by scintillation counting. Background binding
was determined by using a 100 fold excess of unlabelled
thiamine or ThDP in parallel reactions.
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